During the final time slot of the final day, about 50 people attended a talk by Carsten Ehrhardt of Trinity College Dublin titled “Inhalation Biopharmaceutics—Do Transporters Matter in the Lung?”, part of a symposium on “The Best of the Rest—Drug Transport across Non-traditional Biological Barriers.”
An earlier talk by Hugh Smyth of the University of Texas on “Challenges and Future Prospects for Pulmonary Delivery of Biologics” as part of a symposium on “Challenges and Future Prospects for Alternative Delivery of Biologics” was well attended despite the fact that the symposium overlapped with the start of the INTFG meeting.
The only poster session explicitly inclusive of OINDP topics occurred on the final day, with a scattering of pulmonary or nasal posters during other sessions. OINDP-focused posters covered delivery of a variety of compounds, including butyrlcholinesterase for the treatment of organophosphate poisoning, sildenafil, nicotine, coenzyme Q10, and several oncology drugs.
A few posters covered analytical methods, including one from DPT and Proveris Scientific titled “Unit Dose Nasal Sprays: Method Effects of Setting Stroke Length on Spray Characteristics” and a University of Florida poster on “An Optimized Dissolution System for Orally Inhaled Drug Products: Development and Validation.”
Several posters looked at cellulosic excipients for nasal sprays, including one titled, “Feasibility Investigation of Cellulose Polymers for Nasal Drug Delivery Applications” from the University of Michigan and Dow Chemical and “Critical Material Attributes of Dispersible Cellulose in Nasal Sprays” from FMC.
The next AAPS annual meeting will take place November 13–17, 2016 in Denver, Colorado.
